# Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy

> **NCT00802126** · PHASE1 · COMPLETED · sponsor: **University of Campania Luigi Vanvitelli** · enrollment: 16 (actual)

## Conditions studied

- Myopia

## Interventions

- **DRUG:** Combination therapy "IVB + rf-PDT"

## Key facts

- **NCT ID:** NCT00802126
- **Lead sponsor:** University of Campania Luigi Vanvitelli
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-12
- **Final completion:** 2009-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00802126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00802126, "Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00802126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*